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Recent experiments in epithelial wound healing have demonstrated the necessity of Mitogen-
activated protein kinase (MAPK) for coordinated cell movement after damage. This MAPK activity
is characterized by two wave-like phenomena. One MAPK “wave” that originates immediately after
injury, propagates deep into the cell layer, and then rebounds back to the wound interface. After
this initial MAPK activity has largely disappeared, a second MAPK front propagates slowly from
the wound interface and continues into the tissue, maintaining a sustained level of MAPK activity
throughout the cell layer. It has been suggested that the first wave is initiated by reactive oxygen
species (ROS) generated at the time of injury. In this paper, we develop a minimal mechanistic
diffusion-convection model that reproduces the observed behavior. The main ingredients of our
model are a competition between ligand (e.g., Epithelial Growth Factor) and ROS for the activation
of Epithelial Growth Factor Receptor (EGFR) and a second MAPK wave that is sustained by stresses
induced by the slow cell movement that closes the wound. We explore the mathematical properties
of the model in connection with the bistability of the MAPK cascade and look for traveling wave
solutions consistent with the experimentally observed MAPK activity patterns.
PACS numbers: 87.10.Ed, 87.17.Aa.
Introduction
Coordinated cell movement is an essential feature of
many biological processes, such as wound healing, embry-
onic morphogenesis, and tumor growth1. In wound heal-
ing, cell migration and cell contraction are the two main
mechanisms responsible for wound closure. Cell contrac-
tion is the dominant mechanism in the closing of small
wounds through the so called “purse-string” process2.
For larger wounds, cell contraction is not sufficient, and
surrounding cells must migrate to close larger wounds.
While the two mechanisms are not mutually exclusive,
there are cases where cell migration is the only healing
process3, such as when a strip of cells from an epithelial
layer is removed4. Despite the existence of experimen-
tal assays targeting cell migration during wound healing,
there are still many open questions. For instance, be-
fore injury, the cells are resting, but after wounding they
become motile. What mechanical and biochemical phe-
nomena regulate motility? Is it the availability of free
space that leads cells to move toward wound closure?
What determines the speed of cell migration? To be able
to answer these questions, we need to understand both
the mechanical and biochemical aspects of cell migra-
tion, and how they might regulate each other. While the
physical mechanisms of cell movement have been well-
studied3,5,6,7, the complex regulation of the wound heal-
ing process by biochemical signals and feedback pathways
remains poorly understood. Recent experimental inves-
tigations of wounds in epithelial tissue have highlighted
novel properties of the intercellular signaling necessary
for healing8,9.
Matsubayashi et al. (2004) analyzed wounded epithe-
lial monolayers of Madin-Darby canine kidney (MDCK)
cells and showed coordinated movement not only by the
cells at the wound edge, but by several rows of adja-
cent cells. In their experiments, cell proliferation did
not play a significant role. Their study also showed that
the cellular response of the epithelial monolayer is qual-
itatively characterized by two wave-like activation pat-
terns of ERK 1/2, a Mitogen Activated Protein Kinase
(MAPK). These “waves” are characterized by a time-
dependent front of higher ERK 1/2 concentration that
initiates at the wound edge and spreads into the cell layer.
The first rebounding wave-front propagates into the tis-
sue and back to the wound quickly, the second wave-
front is slow and sustains MAPK activity in the tissue
until wound closure. This second, final wave appears to
be related to cell migration through a positive feedback
loop, since inhibition of the second MAPK wave halts co-
ordinated cell movement. Moreover, during this second
“wave”, MAPK is inactive around the healing edges of
the injured layer, but still active in the migrating cells
around the open wound8.
Nikolic´ et al. (2006) extended the experimental anal-
ysis in8 by probing the epithelial wound healing assay
with a novel wound generating technique. They used
polydimethylsiloxane (PDMS) slabs to create two differ-
ent wounding protocols. A peel-off injury is created by
growing part of the epithelial monolayer over a PDMS
slab. Once the slab is peeled-off, taking with it the cells
grown over the PDMS, it creates a wound that breaks
some cells at the wound edge, but leaves the space sur-
rounding the wound free of cellular debris. The other
protocol consists of the removal of a PDMS slab that
2forms the boundary of the cellular monolayer, its re-
moval leaves intact the cells in direct contact with the
slab, but now provides free space at one edge of the
monolayer. This “unconstraining” protocol avoids cell
tearing upon PDMS removal. Experimenting with these
two techniques, and with the standard scratch wound as-
say, the authors confirmed the presence of two separate
waves of MAPK in case of injury. The unconstraining
experiments expressed only the slow, final wave. In this
case, cell movement was limited and random, suggesting
that availability of free space is not enough to generate
an organized migration of the epithelial layer and that
mechanical injury is necessary. Accordingly, scratch and
peel-off experiments resulted in both waves of MAPK
activation and in collective monolayer migration. Using
immunofluorescence, Nikolic´ et al. (2006) were also able
to identify reactive oxygen species (ROS) as one of the
key components of the intercellular signaling responsible
for the observed pattern of MAPK activation. They dis-
covered that ROS are generated immediately after injury
and remain present around the wound edge for at least
the duration of the first rebounding wave. Inhibition of
ROS by N-acetyl-L-cysteine resulted in the absence of
both MAPK waves and cell migration. The results from
the two studies8,9 are summarized in Table I.
In this paper, our aim is to build a mathematical
model that reproduces an that can be used to analyze
the properties of MAPK activation during wound heal-
ing experiments. Because of its relevance and ubiquity,
the MAPK pathway remains the subject of many com-
putational and mathematical modeling studies10. The
MAPK cascade is a signal transduction pathway that re-
lays an external stimulus to the cell, it is characterized
by the sequential activation of three protein kinases11.
Huang and Ferrell12 proposed a system of 18 differen-
tial equations representing the 10 reactions that com-
pose the three-kinase MAPK cascade. A mathematical
and computational analysis of the system showed that
the cascade has the effect of amplifying an input signal
(e.g., receptor phosphorylation) in such a way that its
overall behavior can be compared to that of a coopera-
tive enzyme13. These first computational studies sparked
additional modeling efforts that, coupled with ongoing
discoveries by experimentalists, have led to many more
advanced models that exhibit characteristics (e.g., bista-
bility, ultrasensitivity, oscillations, etc.) of the MAPK
signaling pathway14,15,16,17.
Here, we are not interested in the intracellular dy-
namics of MAPK, but rather on its role within the
wound healing signaling network. For this reason, we
will treat the MAPK cascade as a black box, using the
results in11,18 to essentially represent the whole cascade
as a switch for signal transmission. In this approach,
MAPK/ERK is the output of the “signaling switch”.
ROS are one input that can activate the switch, but
are unlikely to be the only one because of the different
properties of the two activation waves. As suggested in9
and in other wound healing experiments19,20, other in-
Experiment Results
Scratch wound Two MAPK waves, cell migration
Closed wound No MAPK activity, no cell
movement
MAPK inhibition No MAPK waves, no cell migration
Slow wave inhibition No cell migration
Peel-off wound Two MAPK waves, cell migration
Unconstraining
Slow, second wave only, no cell
migration
ROS inhibition No MAPK waves, no cell migration
TABLE I: Summary of the experimental results from8,9.
puts are diffusible ligands and their cell receptors. For
instance, Epidermal Growth Factor (EGF) and EGF Re-
ceptor (EGFR) play essential roles in promoting cell mi-
gration, proliferation and wound closure21,22. Moreover,
positive and negative feedbacks between EGFR signaling
and the MAPK cascade have been demonstrated exper-
imentally and verified computationally23,24,25. Although
Nikolic´ et al. suggest EGF as a possible signal, as well
as other molecules, they did not pursue the topic in
their work. However, they did identify Reactive Oxy-
gen Species (ROS) as direct regulator of MAPK activity
in their wound healing experiments. Since ROS have
been shown to induce EGFR activation in the absence
of EGF26, this finding is in agreement with other stud-
ies that showed the regulatory role of ROS in wound
healing27,28 and MAPK signaling29,30.
Because of the documented connection between dif-
fusible signals, wound healing and MAPK activation,
we propose a mechanistic model based on ligand-
mediated intercellular signaling that reproduces the ob-
served MAPK activation pattern, and that is consistent
with the qualitative experimental features listed in Table
I.
Mathematical Model
The experimental results from8,9 provide evidence of
spatio-temporal MAPK signaling for the regulation of
cell migration during wound healing, without determin-
ing the exact biochemical events that govern it. The
fact that free space by itself is not enough to produce
coordinated cell migration suggests that ROS is not the
only diffusible signal needed to generate the two waves
of MAPK activation. To explain the observed spatio-
temporal MAPK pattern, at least two diffusible signals
are needed. Both ROS and EGFmolecules are able to dif-
fuse in the extracellular space (ROS can also move across
the cell membrane) and both can phosphorylate the EGF
membrane receptor (EGFR), activating the MAPK cas-
cade. EGF induces phosphorylation of the cytoplasmic
tail of EGFR by binding to it. Reynolds et al. (2003)
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FIG. 1: Schematic of biophysical events during wound heal-
ing. (a) diffusible ligands (L) phosphorylate membrane recep-
tors by binding to them, activating the MAPK cascade that
leads to the production of intracellular protease (P). Protease
induces ligand release. (b) ROS (S) can also interact with
membrane receptors by inducing phosphorylation of their cy-
toplasmic tail, which also activates the MAPK cascade and
promotes release of ligands into the extracellular matrix. Dif-
fusible ligand and ROS represent two independent triggers of
the MAPK cascade. (c) Schematic of the three-kinase cas-
cade that characterize MAPK signaling. (d) The stresses
caused by cell movement toward wound closure can lead to
ROS release29,32,33.
showed that ROS can induce EGFR phosporylation even
in the absence of EGF by binding to intracellular phos-
phatases. Also well documented is the positive feed-
back between EGF and the MAPK cascade, and its abil-
ity to produce long range signaling through autocrine
relays31. Finally, ROS can be generated by mechanical
stresses like the ones generated by migration of the ep-
ithelial monolayer29, thus providing a feedback loop be-
tween MAPK activation, cell motility, and further ROS
production. These four signaling mechanisms are sum-
marized in Fig. 1 and constitute the foundation of our
mathematical model.
The wound healing system is a three-dimensional one,
and the migration of individual cells toward wound clo-
sure is not exactly normal to the wound edge as shown by
cell tracking experiments9. Here, we simplify the anal-
ysis by considering the cell layer in cross section as a
semi-infinite straight line, with the wound initially posi-
tioned at the origin. The resulting two-dimensional sys-
tem consists of a semi-infinite cell layer that is immersed
in medium of infinite height (the medium in9 is 3mm
which is much larger than any other length scale in the
problem). We model four species: ROS, one diffusible
ligand (e.g., EGF), one ligand receptor (e.g., EGFR)
and playing the role of the output of the MAPK cascade
“black box”, a protease that is the intracellular precur-
sor of the ligand (e.g., the piece completing the feedback
loop between EGF and the MAPK cascade in Figs. 1-
(a) and 1-(b)). We denote the local concentrations of
these species by L, S, R, and P respectively. As de-
picted in Fig. 1, the signal can be transmitted to the cell
in two different ways: through a ligand-receptor complex
(CL ≡ R ·L) and a ROS-receptor complex38 (CS ≡ R ·S).
We will assume that the number of available cell mem-
brane receptors is in excess, implying that R is approxi-
mately constant and that ROS-ligand-receptor complexes
are negligible.
A schematic representation of the system is given in
Fig. 2. The governing equations and boundary condi-
tions of our model are
∂L(X,Z, T )
∂T
= DL
(
∂2L(X,Z, T )
∂X2
+
∂2L(X,Z, T )
∂Z2
)
, L(X,Z =∞, T ) = 0, (1)
DL
∂L(X, 0, T )
∂Z
= kLonRL(X, 0, T )− kLoffCL(X,T )− gLP (X,T ), (2)
∂CL(X,T )
∂T
= kLonRL(X, 0, T )−
(
kLoff + k
L
ec
)
CL(X,T ), (3)
∂S(X,Z, T )
∂T
= DS
(
∂2S(X,Z, T )
∂X2
+
∂2S(X,Z, T )
∂Z2
)
, S(X,Z =∞, T ) = 0, (4)
DS
∂S(X, 0, T )
∂Z
= kSonRS(X, 0, T )− gSΠS(CL, X, T ), (5)
∂CS(X,T )
∂T
= kSonRS(X, 0, T )− kSecCS(X,T ), (6)
∂P (X,T )
∂T
= −kPP (X,T ) + gP ΠP (CL, CS) . (7)
Equations (1) and (4) describe the diffusion of ligands and ROS in the extracellular medium with homogeneous
4diffusion constant DL and DS, respectively. Eqn. (2)
accounts for the flux of ligand across the surface of the
cellular layer including ligand-receptor complex forma-
tion with rate constant kLon, ligand-receptor complex dis-
sociation with rate constant kLoff , and extracellular ligand
release by intracellular protease with rate gL. Eqn. (3)
governs the kinetics of ligand-receptor complexes, with
new complexes forming at rate kLon and dissociating with
rate kLoff , k
L
ec represents the rate of receptor-mediated en-
docytosis of the ligand-bound receptor complexes. Eqn.
(5) describes the diffusive flux of ROS due to formation of
ROS-receptor complexes with rate kSon and to ROS pro-
duction by the functional ΠS(CL, X, T ). The kinetics of
ROS-receptor complexes is represented by Eqn. (6) and
its terms are analogous to the ones in Eqn. (3), except
that there is no ROS release from the ROS-receptor com-
plex in accordance with26. The last equation describes
the cellular response to extracellular signaling through
the activity of intracellular proteases. Within the wound
healing framework, protease activity is directly related
to ERK1/2 activity measured in9. In particular, the pro-
tease dynamics is characterized by a degradation term
with rate constant kP and a source term ΠP(CL, CS) with
maximum production rate gP. To complete the descrip-
tion of the mathematical model, we need to impose rea-
sonable functional forms for ΠP and ΠS.
The role of the functional ΠP(CL, CS) is to represent
the intermediate biochemical steps that lead to protease
production. These steps include the MAPK cascade and
any other reaction in the feedback loop between ligand
binding and ligand release (e.g., the solid box in Fig. 1-
(c)). In the literature, ΠP is usually represented as a
sigmoidal function of cell surface complexes such as the
Hill function11,18,34. If the level of receptor signaling is
given by the total concentration of complexes (CL+CS),
we propose the following functional form:
ΠP(CL, CS) =
(CL + CS)
n
CnA + (CL + CS)
n , (8)
where n is an effective Hill coefficient, and CA represents
an activation threshold of the signaling pathway.
Defining the ROS source ΠS is more problematic since
the experimental evidence suggests an interplay between
cellular signaling and cell migration, thus involving me-
chanical forces whose description goes beyond the scope
of this paper. Conversely, the production of ROS due
to wound induction is embedded in the initial conditions
of the system and it is not described in ΠS. Generally,
ROS production increases with cell metabolism29. In our
case, metabolic increase may be related to cells becom-
ing motile29,33 and/or to ligand signaling32. We use a Hill
function multiplied by a decaying exponential to repre-
sent ΠS:
ΠS(CL, X, T ) =
{
0 T < TD
(CL(X,T−TD))
m
Sm
A
+(CL(X,T−TD))
m e−kxX T ≥ TD .
(9)
The Hill functional represents ligand-mediated ROS pro-
duction stemming from the phosphorylation of a recep-
tor’s tail during ligand binding. The delay TD represents
the delay between ligand binding and ROS production.
Finally, the exponential factor in Eqn. (9) describes re-
duction in ROS production due to the decrease in motil-
ity from cells near the wound edge (X = 0) to cells farther
from it.
Upon introducing the following dimensionless quanti-
ties
t = kPT, x = X
√
kP
DL
, z = Z
√
kP
DL
,
l = L
kPk
L
eck
L
onR
gLgP
(
kLoff + k
L
ec
) , cL = CL kPkLec
gLgP
, cS = CS
kSec
gS
,
s = S
kSonR
gS
, p = P
kP
gP
,
we express the system of equations in dimensionless form:
∂l(x, z, t)
∂t
=
∂2l(x, z, t)
∂x2
+
∂2l(x, z, t)
∂z2
, (10)
α lz(x, 0, t) = l(x, 0, t)−
− β [l(x, 0, t)− cL(x, t)] − p(x, t), (11)
ε
∂cL(x, t)
∂t
= l(x, 0, t)− cL(x, t), (12)
δ
∂cS(x, t)
∂t
= s(x, 0, t)− cS(x, t), (13)
∂s(x, z, t)
∂t
= η
(
∂2s(x, z, t)
∂x2
+
∂2s(x, z, t)
∂z2
)
, (14)
ν sz(x, 0, t) = s(x, 0, t)− pis(cL, x, t), (15)
∂p
∂t
= −p+ pip (cL, cS) , (16)
where the dimensionless parameters are
α =
√
DLkP
(
kLoff + k
L
ec
)
kLonRk
L
ec
, β =
kLoff
kLec
, δ =
kP
kSec
,
ε =
kP
kLoff + k
L
ec
, η =
DS
DL
, ν =
√
kP
DL
DS
kSonR
.
(17)
The parameters α and ν characterize the relative rates of
diffusion and binding, while β represents the strength of
complex degradation relative to ligand dissociation. The
parameters ε and δ describe the speed of binding and
endocytosis relative to ligand release mediated by intra-
cellular species, and η is the ratio of diffusivity between
ROS and EGF ligand.
5P
DS
S
onk CS
DL
L
onk
L
offk
S
eck Leck
MAPK
S
L
x
nucleus
z CL
FIG. 2: Schematic of simplified signaling pathway during
wound healing: ligands (L) and ROS (S) are free to dif-
fuse and bind to cell surface receptors. This binding forms
complexes (CS and CL) that activate MAPK signaling. Com-
plexes are lost due to endocytosis or, in the case of ligand-
receptor complexes, through ligand unbinding and endocyto-
sis. Intracellular proteases (P ) release extracellular ligands
(L).
The dimensionless protease and ROS production func-
tions become
pip(cL, cS) =
(cL + γ cS)
n
cnA + (cL + γ cS)
n , (18)
pis(cL, x, t) =


0 t < τ
(cL(x, t− τ))m
smA + (cL(x, t− τ))m
e−λx t ≥ τ ,(19)
where cA = CA(kPk
L
ec)/(gLgP), γ = (gSkPk
L
ec)/(gLgPk
S
ec),
τ = TDkP, λ = kxL, and sA = (SAkPk
L
ec)/(gLgP).
Fast Binding Approximation
Before we proceed to the analysis of the model, we are
going to make an assumption that significantly simpli-
fies the model and that is also justifiable biophysically.
We assume that ligand dissociation and complex degra-
dation is fast compared to protease degradation, e.g.,
kP ≪ kSec, kLoff , kLec. In this limit, ε and δ are small and
Eqns. (12) and (13) can be treated as a singular per-
turbation. On timescales of protease degradation the
concentration of ligand-receptor and ROS-receptor com-
plexes are approximately that of the surface concentra-
tion of free ligand and ROS, respectively. If we consider
only the “outer” solutions of Eqns. (12) and (13) , our
full model reduces to the three equations:
∂l(x, z, t)
∂t
=
∂2l(x, z, t)
∂x2
+
∂2l(x, z, t)
∂z2
, (20)
α lz(x, 0, t) = l(x, 0, t)− p(x, t), (21)
∂s(x, z, t)
∂t
= η
(
∂2s(x, z, t)
∂x2
+
∂2s(x, z, t)
∂z2
)
, (22)
ν sz(x, 0, t) = s(x, 0, t)− pis(l, x, t), (23)
∂p
∂t
= −p+ pip (l, s) , (24)
FIG. 3: Steady state configurations. (a) Graphical solution
of Eqn. (26) for s¯ = 0.1, and cA = 0.7. There are three
solutions representing two stable steady states (l¯0 and l¯2) and
one unstable equilibrium (l¯1). (b) If we fix the activation
threshold (cA = 0.7), different values of ROS concentration
lead to different steady state configurations. Bistability is
possible if there is enough ROS, otherwise the only stable
steady state is the one with no MAPK activity. (c) We fix
ROS concentration to s¯ = 0.1 and graphically solve Eqn. (26)
for different values of cA. Bi-stability can arise only if the
activation threshold is sufficiently small. The Hill coefficient
n = 8 was used in all plots.
where all functions now represent “outer” solutions valid
at times beyond initial transients in complex formation.
We verified that this approximation holds throughout all
of the analysis performed in the next section.
Analysis & Results
The spatio-temporal MAPK activation patterns can
arise from different mechanisms. For example, one (or
more) activation pattern could consist of a traveling front
connecting two stable steady states, corresponding to
high and low MAPK concentrations. In this section we
describe the steady states of the system of Eqns. (20)-
(24) and present an overview of the qualitative behavior
of the solutions of the model. After establishing the dy-
namics of the mathematical model, we use the known
model parameters to determine the nature of the MAPK
patterns and some of their properties.
The complexity of our model requires analysis through
numerical simulations. For this purpose we use an ex-
plicit finite difference scheme that is forward in time and
centered in space, implemented in Fortran. We use a
uniform grid discretization along the direction of the cell
layer (e.g., x) and a geometrical grid discretization along
the direction normal to the cell layer (e.g., z) to max-
imize accuracy and minimize run-time. This approach
and its advantages have been previously described in35.
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FIG. 4: Traveling waves connecting the state of MAPK ac-
tivation and the state of MAPK inactivity can move toward
or away from the wound depending on ROS concentration at
cell layer level (s¯) and activation threshold (cA) when n→∞.
The thick black line indicates conditions under which the front
is not moving. Regimes above the line lead to traveling waves
moving toward the wound, while those below the line lead to
fronts moving away from the wound.
Steady States & Traveling Fronts
The steady states of the model in Eqs. (20)-(24) sat-
isfy:
l¯ = p, s¯ = pis(l¯, x, t), and p = pip(l¯, s¯), (25)
where the overbar indicates that the value of ligand or
ROS concentration is taken at z = 0 (e.g., l¯ = l(x, z =
0, t)). The resulting condition
l¯ = pip(l¯, s¯) (26)
is always satisfied by the trivial solution (l¯ = 0, s¯ = 0),
but under certain conditions it can have two more solu-
tions as highlighted in Fig. 3-(a). In this case the three
roots are two stable steady states, l¯0 and l¯2, and an un-
stable one, l¯1. The two stable steady states represent a
state of no ligand signaling, l¯0 = 0, and a state of active
ligand signaling, l¯2 > 0, respectively. From Fig. 3 we
can also infer how ROS concentration s¯ and the activa-
tion threshold cA control the steady states of the system.
If we fix the activation threshold at a sufficiently high
value, the system attains only the trivial steady state,
l¯ = l¯0 = 0, unless there is enough ROS to sustain the
signaling pathway, as shown in Fig. 3-(b). Conversely, if
we fix s¯, the system will be bistable only if the activation
threshold cA is sufficiently small (Fig. 3-(c)).
Bistability implies that the model admits traveling
front solutions connecting the two stable steady states.
We can approximate the front speed analytically by con-
sidering a simpler scenario in which the concentration
of ROS at cell layer level, s¯, is constant and take the
limit n → ∞ for the Hill coefficient of pip. In this limit,
the sigmoidal protease production function pip equals the
Heaviside function centered at cA − s¯:
lim
n→∞
pip(l¯, s¯) = H(l¯+ s¯− cA) =
{
1 l¯ ≥ cA − s¯
0 l¯ < cA − s¯
. (27)
In this limit the system is bistable for 0 < cA − s¯ < 1,
and the roots of Eqn. 26 are l¯0 = 0, l¯1 = cA − s¯, and
l¯2 = 1. Furthermore, we can determine the velocity and
direction of the traveling fronts by proceeding as in36,
obtaining:
cA − s¯ =
1
pi
∫
∞
αv
α
√
q2 − vq
q(1 + vq)(α2q2 − α2vq + 1) dq, (28)
which gives an implicit relation for v, the velocity of the
traveling wave for a fixed concentration of ROS. The in-
tegration variable q in the above integral arises from the
Fourier transformation used to derive Eqn. 28. From
Eqn. 28 we find that the front velocity is a monoton-
ically increasing function of the parameter α (see Eqn.
17). This result is expected since an increase in α cor-
responds to either an increase in ligand diffusivity or a
decrease in ligand binding, and both changes result in
the front reaching farther distances in a shorter amount
of time. The direction of the front is determined by the
threshold cA − s¯. If cA − s¯ < 1/2, the front of active
MAPK will move away from the wound, and deep into
the cell layer. If cA− s¯ > 1/2, MAPK activity will recede
toward the wound. Regimes that delineate forward and
backward traveling MAPK waves are indicated in Fig. 4.
These results provide useful insight for the general case of
n < ∞ and diffusing ROS. Numerical simulations show
that for Hill coefficient as low as n = 6, the instantaneous
front velocity is within 10% of that obtained from Eqn.
28. To summarize, we showed that the system can have
two stable steady states and that traveling wave solutions
connecting them are possible. In particular, ROS can de-
termine the existence, velocity and direction of the fronts
by effectively regulating the activation threshold of the
MAPK cascade.
ROS/EGF regulation of MAPK activation
Bistability is necessary but not sufficient for the ex-
istence of traveling wave solutions. In this section we
explore the parameter space of the wound healing assay
to determine the nature of the MAPK fronts observed
in8,9. To avoid ambiguity, we divide the MAPK dynam-
ics during wound healing into three wave-like events. The
first event corresponds to the fast activation of MAPK
initiated by the wound. It lasts until the activation front
7Parameter Typical Value Ref.
DL 10
−8
− 10−6 cm2s−1 31
kLon 10
−15
− 10−12 cm3s−1 31
kLoff 10
−3
− 10−2 s−1 31
kLec 10
−3
− 10−2 s−1 31
kP 10
−4
− 10−3 s−1 31
R 1010 − 1013 cm−2 31
gP 0.17 × 10
8 cm−2 s−1 36
gL 0.54 × 10
−2 s−1 37
CA 10
9 cm−2 37
TABLE II: Typical values of model parameters.
reaches its maximum depth in the cell layer. The sec-
ond event is characterized by decrease of MAPK activ-
ity. It moves from deep into the epithelial monolayer
toward the wound. These first two events qualitatively
correspond to the first “rebounding wave” observed in
the experiments8,9. The last event consists of a slow ac-
tivation front that starts at the wound edge and moves
away from the wound. This last “wave” is initiated when
the cells in the layer start moving to close the wound it-
self, and is sustained when the wound is large, preventing
closure in finite time9.
To reproduce the observed MAPK dynamics, we nu-
merically integrated Eqns. (20)-(24) using the ligand re-
lated parameters given in Table II. Although we could
not find analogous references for physical parameters
of ROS, we estimated parameter values from various
sources. We used the self-diffusivity of water together
with the Einstein relation to bound the value of η be-
tween 10 and 100. From the results in26 it seems rea-
sonable to assume kSec ≈ kLec. We assume that the ini-
tial concentration of ligand and protease is zero, while
the concentration of ROS is represented by a narrow
Gaussian with width equal to the size of a single cell;
it represents the ROS initially released by cell rupture.
Our numerical results are summarized in Figs. 5 and 6.
Fig. 5 compares the time evolution of the distance of the
front from the wound as predicted by Eqns.(20)-(24) with
the experimental values observed in9 for scratch wounds.
The position of the front is determined by evaluating
the inflection point of protease concentration after each
time step. The model is able to replicate the observed
MAPK behavior and we used it to investigate the dy-
namics of the three activation wave-like patterns. Fig.
6 shows the time evolution of the profiles of the three
MAPK “waves”. The first wave (Fig. 6-(a)) is driven by
ROS production at the onset of wound and its fast diffu-
sion. However, there is not enough ROS for either ligand
or protease concentration to reach the signaling steady
state (e.g., p = l¯ = 1). As a result, the first “wave”
can only propagate as far as ∼ 480µm before receding.
As ROS diffuses away, protease concentrations decrease
(Fig. 6-(b)) until the cells start to move (after about 30
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FIG. 5: Time evolution of the distance from the wound edge
of the MAPK front. The circles and the intersecting vertical
bars represent the average front position and one standard
deviation error bars, respectively. Their values have been
obtained from the experimental data in9. The solid trace has
been obtained through a computer simulation of Eqns. (20)-
(24) with dimensionless parameters: α = 0.35, η = 16, ν = 5,
cA = 0.625, n = 6, γ = 2, pA = 0.975, m = 9, λ = 0.55,
τ = 2.56. These parameters are based on kP = 5.6×10
−3s−1,
DL = 5.6 × 10
−7cm2s−1, kLec = k
L
off = 10
−2s−1, gL = 0.54 ×
10−2s−1, gP = 0.17×10
8cm−2s−1, R = 3.2×1011cm−2, kLon =
10−15cm3s−1, CA = 10
9cm−2.
minutes from injury). At that time, ROS is produced
by the moving cells and fuels the positive feedback loop
between ligand and protease. The nonlinear effects of pip
allow protease levels to increase until they reach a sig-
naling steady-state. At this point, the front moves like
a true traveling-wave (Fig. 6-(c)), with its speed and
distance traveled regulated by the ROS source function
pis. We can also track the time-evolution of the variables
in the model. Fig. 6-(d) shows how protease concentra-
tion at the wound edge x = 0 changes in time. From
this graph we observe that during the first MAPK event
the protease concentration never reaches the “signaling”
steady-state p ≈ 1 and eventually decreases. During the
third wave, protease concentration reaches the “signal-
ing” steady-state and remains there as shown by the flat
part of the graph in Fig. 6-(d). To summarize, only
the third MAPK front behaves as a true traveling wave,
while the initial two events (corresponding to the first
“rebounding wave” observed in experiments) are actu-
ally transient, diffusion-driven patterns.
Conclusions
We have formulated a mathematical model for the dy-
namics of intercellular signaling observed during wound
healing experiments. From this model, we were able
to replicate the signaling patterns observed in8,9, and
to provide insight regarding their nature. Our choice
of EGF as signaling ligand is based upon literature re-
view, but lacks experimental evidence within the epithe-
lial wound healing assay. However, we showed that the
properties of EGF (and EGFR) fit the profile for the
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FIG. 6: Time evolution of protease. (a) After injury, the
fast diffusion of ROS drives MAPK activation. (b) As ROS
diffuses away, the positive feedback loop between MAPK and
ligand is not strong enough to sustain signaling and the depth
of the front decreases. (c) Once the cells start moving, ROS
production and the ligand-protease feedback loop fuel the ac-
tivation front. (d) Time evolution of protease concentration
at x = 0. The parameters used to obtain these plots are the
same as the ones used to generate Fig. 5.
unidentified diffusible signals mentioned in9. Our model
can be expanded to incorporate other diffusible signaling
molecules. Although it may be possible to find physio-
logically realistic sets of parameters that lead to signaling
patterns consisting of three separate traveling waves, the
parameters associated with the EGF/ROS/MAPK sys-
tem lead to only one final traveling wave. The first two
notable events being described by purely diffusive and
decays dynamics, respectively.
An aspect of our current model that needs improve-
ment and further analysis is the determination of the
ROS source function ΠS. From the experiments in
9,
this term seems to be negligible since they only detected
the presence of extracellular ROS up to ∼ 10min
after wounding. However, there is substantial evidence
indicating that cell motility and ligand-receptor binding
can induce ROS production. A plausible explanation
for these conflicting results could be that ROS produced
after wounding is fully recaptured by intracellular
processes (including EGFR phosphorylation) and never
crosses the cell membrane. Nonetheless, we performed
many numerical tests and found that if ΠS = 0 (data not
shown), then all three MAPK events are diffusion driven
and the signaling pattern is due to the different diffusion
properties of ROS and ligand (EGF). A more physically
realistic approach might be to include the mechanical
events that take place within the cell layer and the
reaction that lead to ROS production after ligand bind-
ing. Such an approach could provide important insights
about the mechanisms of post -wound ROS production
and their relevance within the MAPK signaling context.
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